aluates Reports

$ 0.0

Automative

Global Stomach Cancer Molecular Diagnostics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-6M6119

Global Stomach Cancer Molecular Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Stomach Cancer Molecular Diagnostics Market Research Report 2025

Code: QYRE-Auto-6M6119

Report

June 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Genetech

Amoydx

Sinomdgene

Genetronhealth

Premed

Berryoncology

Gene+

Helixgen

Annoroad

Topgen

Geneis

Stomach Cancer Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Stomach Cancer Molecular Diagnostics Market

The global market for Stomach Cancer Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A molecular approach for diagnosing stomach cancer

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Stomach Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stomach Cancer Molecular Diagnostics.

The Stomach Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stomach Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stomach Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Stomach Cancer Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Stomach Cancer Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR FISH DNA Sequencing Gene Chip
Segment by Application	Clinical Diagnosis Drug Screening Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Genetech, Amoydx, Sinomdgene, Genetronhealth, Premed, Berryoncology, Gene+, Helixgen, Annoroad, Topgen, Geneis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stomach Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Stomach Cancer Molecular Diagnostics Market report?

Ans: The main players in the Stomach Cancer Molecular Diagnostics Market are Genetech, Amoydx, Sinomdgene, Genetronhealth, Premed, Berryoncology, Gene+, Helixgen, Annoroad, Topgen, Geneis

What are the Application segmentation covered in the Stomach Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Stomach Cancer Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Stomach Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Stomach Cancer Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 PCR

1.2.3 FISH

1.2.4 DNA Sequencing

1.2.5 Gene Chip

1.3 Market by Application

1.3.1 Global Stomach Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Stomach Cancer Molecular Diagnostics Market Perspective (2020-2031)

2.2 Global Stomach Cancer Molecular Diagnostics Growth Trends by Region

2.2.1 Global Stomach Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Stomach Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Stomach Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Stomach Cancer Molecular Diagnostics Market Dynamics

2.3.1 Stomach Cancer Molecular Diagnostics Industry Trends

2.3.2 Stomach Cancer Molecular Diagnostics Market Drivers

2.3.3 Stomach Cancer Molecular Diagnostics Market Challenges

2.3.4 Stomach Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Stomach Cancer Molecular Diagnostics Players by Revenue

3.1.1 Global Top Stomach Cancer Molecular Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Stomach Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Stomach Cancer Molecular Diagnostics Revenue

3.4 Global Stomach Cancer Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Stomach Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer Molecular Diagnostics Revenue in 2024

3.5 Global Key Players of Stomach Cancer Molecular Diagnostics Head office and Area Served

3.6 Global Key Players of Stomach Cancer Molecular Diagnostics, Product and Application

3.7 Global Key Players of Stomach Cancer Molecular Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Stomach Cancer Molecular Diagnostics Breakdown Data by Type

4.1 Global Stomach Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)

5 Stomach Cancer Molecular Diagnostics Breakdown Data by Application

5.1 Global Stomach Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Stomach Cancer Molecular Diagnostics Market Size (2020-2031)

6.2 North America Stomach Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025)

6.4 North America Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Stomach Cancer Molecular Diagnostics Market Size (2020-2031)

7.2 Europe Stomach Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025)

7.4 Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Stomach Cancer Molecular Diagnostics Market Size (2020-2031)

9.2 Latin America Stomach Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Genetech

11.1.1 Genetech Company Details

11.1.2 Genetech Business Overview

11.1.3 Genetech Stomach Cancer Molecular Diagnostics Introduction

11.1.4 Genetech Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.1.5 Genetech Recent Development

11.2 Amoydx

11.2.1 Amoydx Company Details

11.2.2 Amoydx Business Overview

11.2.3 Amoydx Stomach Cancer Molecular Diagnostics Introduction

11.2.4 Amoydx Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.2.5 Amoydx Recent Development

11.3 Sinomdgene

11.3.1 Sinomdgene Company Details

11.3.2 Sinomdgene Business Overview

11.3.3 Sinomdgene Stomach Cancer Molecular Diagnostics Introduction

11.3.4 Sinomdgene Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.3.5 Sinomdgene Recent Development

11.4 Genetronhealth

11.4.1 Genetronhealth Company Details

11.4.2 Genetronhealth Business Overview

11.4.3 Genetronhealth Stomach Cancer Molecular Diagnostics Introduction

11.4.4 Genetronhealth Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.4.5 Genetronhealth Recent Development

11.5 Premed

11.5.1 Premed Company Details

11.5.2 Premed Business Overview

11.5.3 Premed Stomach Cancer Molecular Diagnostics Introduction

11.5.4 Premed Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.5.5 Premed Recent Development

11.6 Berryoncology

11.6.1 Berryoncology Company Details

11.6.2 Berryoncology Business Overview

11.6.3 Berryoncology Stomach Cancer Molecular Diagnostics Introduction

11.6.4 Berryoncology Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.6.5 Berryoncology Recent Development

11.7 Gene+

11.7.1 Gene+ Company Details

11.7.2 Gene+ Business Overview

11.7.3 Gene+ Stomach Cancer Molecular Diagnostics Introduction

11.7.4 Gene+ Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.7.5 Gene+ Recent Development

11.8 Helixgen

11.8.1 Helixgen Company Details

11.8.2 Helixgen Business Overview

11.8.3 Helixgen Stomach Cancer Molecular Diagnostics Introduction

11.8.4 Helixgen Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.8.5 Helixgen Recent Development

11.9 Annoroad

11.9.1 Annoroad Company Details

11.9.2 Annoroad Business Overview

11.9.3 Annoroad Stomach Cancer Molecular Diagnostics Introduction

11.9.4 Annoroad Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.9.5 Annoroad Recent Development

11.10 Topgen

11.10.1 Topgen Company Details

11.10.2 Topgen Business Overview

11.10.3 Topgen Stomach Cancer Molecular Diagnostics Introduction

11.10.4 Topgen Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.10.5 Topgen Recent Development

11.11 Geneis

11.11.1 Geneis Company Details

11.11.2 Geneis Business Overview

11.11.3 Geneis Stomach Cancer Molecular Diagnostics Introduction

11.11.4 Geneis Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025)

11.11.5 Geneis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Genetech

Amoydx

Sinomdgene

Genetronhealth

Premed

Berryoncology

Gene+

Helixgen

Annoroad

Topgen

Geneis

List of Tables

Table 1. Global Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of PCR

Table 3. Key Players of FISH

Table 4. Key Players of DNA Sequencing

Table 5. Key Players of Gene Chip

Table 6. Global Stomach Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Stomach Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Stomach Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Stomach Cancer Molecular Diagnostics Market Share by Region (2020-2025)

Table 10. Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Stomach Cancer Molecular Diagnostics Market Share by Region (2026-2031)

Table 12. Stomach Cancer Molecular Diagnostics Market Trends

Table 13. Stomach Cancer Molecular Diagnostics Market Drivers

Table 14. Stomach Cancer Molecular Diagnostics Market Challenges

Table 15. Stomach Cancer Molecular Diagnostics Market Restraints

Table 16. Global Stomach Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Stomach Cancer Molecular Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Stomach Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer Molecular Diagnostics as of 2024)

Table 19. Ranking of Global Top Stomach Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Stomach Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Stomach Cancer Molecular Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Stomach Cancer Molecular Diagnostics, Product and Application

Table 23. Global Key Players of Stomach Cancer Molecular Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Stomach Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Stomach Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Genetech Company Details

Table 49. Genetech Business Overview

Table 50. Genetech Stomach Cancer Molecular Diagnostics Product

Table 51. Genetech Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Genetech Recent Development

Table 53. Amoydx Company Details

Table 54. Amoydx Business Overview

Table 55. Amoydx Stomach Cancer Molecular Diagnostics Product

Table 56. Amoydx Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Amoydx Recent Development

Table 58. Sinomdgene Company Details

Table 59. Sinomdgene Business Overview

Table 60. Sinomdgene Stomach Cancer Molecular Diagnostics Product

Table 61. Sinomdgene Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Sinomdgene Recent Development

Table 63. Genetronhealth Company Details

Table 64. Genetronhealth Business Overview

Table 65. Genetronhealth Stomach Cancer Molecular Diagnostics Product

Table 66. Genetronhealth Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 67. Genetronhealth Recent Development

Table 68. Premed Company Details

Table 69. Premed Business Overview

Table 70. Premed Stomach Cancer Molecular Diagnostics Product

Table 71. Premed Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Premed Recent Development

Table 73. Berryoncology Company Details

Table 74. Berryoncology Business Overview

Table 75. Berryoncology Stomach Cancer Molecular Diagnostics Product

Table 76. Berryoncology Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 77. Berryoncology Recent Development

Table 78. Gene+ Company Details

Table 79. Gene+ Business Overview

Table 80. Gene+ Stomach Cancer Molecular Diagnostics Product

Table 81. Gene+ Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Gene+ Recent Development

Table 83. Helixgen Company Details

Table 84. Helixgen Business Overview

Table 85. Helixgen Stomach Cancer Molecular Diagnostics Product

Table 86. Helixgen Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 87. Helixgen Recent Development

Table 88. Annoroad Company Details

Table 89. Annoroad Business Overview

Table 90. Annoroad Stomach Cancer Molecular Diagnostics Product

Table 91. Annoroad Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 92. Annoroad Recent Development

Table 93. Topgen Company Details

Table 94. Topgen Business Overview

Table 95. Topgen Stomach Cancer Molecular Diagnostics Product

Table 96. Topgen Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 97. Topgen Recent Development

Table 98. Geneis Company Details

Table 99. Geneis Business Overview

Table 100. Geneis Stomach Cancer Molecular Diagnostics Product

Table 101. Geneis Revenue in Stomach Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 102. Geneis Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Stomach Cancer Molecular Diagnostics Picture

Figure 2. Global Stomach Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Stomach Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. PCR Features

Figure 5. FISH Features

Figure 6. DNA Sequencing Features

Figure 7. Gene Chip Features

Figure 8. Global Stomach Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Stomach Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Clinical Diagnosis Case Studies

Figure 11. Drug Screening Case Studies

Figure 12. Research Case Studies

Figure 13. Stomach Cancer Molecular Diagnostics Report Years Considered

Figure 14. Global Stomach Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Stomach Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Stomach Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Stomach Cancer Molecular Diagnostics Market Share by Players in 2024

Figure 18. Global Top Stomach Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer Molecular Diagnostics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Stomach Cancer Molecular Diagnostics Revenue in 2024

Figure 20. North America Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Stomach Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Stomach Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Share by Region (2020-2031)

Figure 34. China Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Stomach Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Genetech Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 50. Amoydx Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 51. Sinomdgene Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 52. Genetronhealth Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 53. Premed Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 54. Berryoncology Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 55. Gene+ Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 56. Helixgen Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 57. Annoroad Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 58. Topgen Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 59. Geneis Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

Global Skin Cancer Molecular Diagnostics Market Research Report 2024

Global Precancer Molecular Diagnostics Market Research Report 2024

Global Chest Cancer Molecular Diagnostics Market Research Report 2024

Global Brain Cancer Molecular Diagnostics Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Testicular Cancer Market Research Report 2024

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Esophageal Cancer Molecular Diagnosis Market Research Report 2024

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Pancreatic Cancer Molecular Diagnostics Market Research Report 2024

Global Bladder Cancer Molecular Diagnostics Market Research Report 2024

Global Melanoma Molecular Diagnostics Market Research Report 2024

Global Laryngeal Cancer Molecular Diagnostics Market Research Report 2024

Global Lymphoma Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Research Report 2024

Global Kidney Cancer Molecular Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions